Literature DB >> 16985731

Immunotherapy and peripheral-blood transplant for metastatic renal cell carcinoma.

B Patel, K Michel, A Belldegrun.   

Abstract

Entities:  

Year:  2000        PMID： 16985731      PMCID： PMC1476099     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  6 in total

1.  Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Authors:  S A Rosenberg; M T Lotze; J C Yang; P M Aebersold; W M Linehan; C A Seipp; D E White
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

2.  Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study.

Authors:  M M Walther; J C Lyne; S K Libutti; W M Linehan
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

3.  Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

Authors:  R W Childs; E Clave; J Tisdale; M Plante; N Hensel; J Barrett
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

4.  Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.

Authors:  R Figlin; B Gitlitz; J Franklin; F Dorey; N Moldawer; J Rausch; J deKernion; A Belldegrun
Journal:  Cancer J Sci Am       Date:  1997-12

5.  Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place.

Authors:  J R Wagner; M M Walther; W M Linehan; D E White; S A Rosenberg; J C Yang
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

6.  Cytoreductive surgery in the management of metastatic renal cell carcinoma: the UCLA experience.

Authors:  J R Franklin; R Figlin; J Rauch; B Gitlitz; A Belldegrun
Journal:  Semin Urol Oncol       Date:  1996-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.